Studies on the role of LRRK2 in Parkinson's disease involve collaboration with:
Canadian LRRK2 in Inflammation Team (CLINT) Investigators which includes: Earl Brown (uOttawa), Derrick Gibbings (uOttawa), Shawn Hayley (Carleton), David Park (uOttawa), Dana C Philpott (U. of Toronto), John D. Rioux (U. de Montreal), Michael Schlossmacher (uOttawa), and Erwin Schurr (McGill)
Studies on the use of mGlur5 allosteric modulation as a means of recovery in Parkinson's disease are in collaboration with:
Stephen Ferguson, uOttawa, Ottawa, ON
Studies on the role of TrkB signalling and depression in collaboration with:
Barbara Fenner, Kings College, Wilkes-Barre, PA
Studies concerning the link between neuronal firing patterns and neurodegeneration.
Hongyu Sun, Carleton U., Ottawa, ON